Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | PPARD | Q03181 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8643733 | 0.84 | TSHR (0.57) | TSHRPPARDTDP1TP53MAPT | |
| SCHEMBL18250731 | 0.82 | TSHR (0.55) | TSHRPPARDTDP1TP53MAPT | |
| SCHEMBL2994532 | 0.81 | MEN1 (0.35) | TSHRPPARDTDP1CA12CA1 | |
| SCHEMBL7196403 | 0.80 | PPARD (0.39) | TSHRPPARDMAPT | |
| SCHEMBL6051814 | 0.80 | TSHR (0.52) | TSHRPPARDTDP1TP53MAPT | |
| SCHEMBL282439 | 0.80 | TSHR (0.52) | TSHRPPARDTDP1TP53MAPT | |
| SCHEMBL2857622 | 0.78 | TSHR (0.50) | TSHRPPARDTDP1TP53MAPT | |
| SCHEMBL16092576 | 0.78 | TSHR (0.50) | TSHRPPARDTDP1TP53MAPT | |
| SCHEMBL712616 | 0.78 | TSHR (0.50) | TSHRPPARDTDP1TP53MAPT | |
| SCHEMBL246310 | 0.78 | TSHR (0.50) | TSHRPPARDTDP1TP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 335 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400793-A1 | COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. | 2024-12-05 | — | — | US | claimed |
| EP-4396271-A1 | COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF | Momentive Performance Materials Inc. (US) | 2024-07-10 | — | — | EP | claimed |
| CN-117843599-A | Preparation method of prostaglandin intermediate containing 1-alkyl-1-alkenyl ethanol structure | 广州楷石医药有限公司 | 2024-04-09 | — | — | CN | claimed |
| WO-2023034354-A1 | COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2023-03-09 | — | — | WO | claimed |
| EP-2545583-B1 | METHODS AND COMPOSITIONS FOR DOPING SILICON SUBSTRATES WITH MOLECULAR MONOLAYERS | VERSUM MAT US LLC (US) | 2020-05-13 | — | — | EP | claimed |
| CN-103189969-B | Method and composition for doping silicon substrate with molecular monolayer | 戴纳洛伊有限责任公司 | 2017-03-22 | — | — | CN | claimed |
| CN-106214496-A | A kind of dental prosthetic filled compositions and preparation method thereof | 林春梅 | 2016-12-14 | — | — | CN | claimed |
| US-9150498-B2 | Process for the preparation of oseltamivir and methyl 3-epi-shikimate | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-10-06 | — | — | US | claimed |
| EP-2771311-A1 | PROCESS FOR THE PREPARATION OF OSELTAMIVIR AND METHYL 3-EPI-SHIKIMATE | Council of Scientific & Industrial Research (IN) | 2014-09-03 | — | — | EP | claimed |
| US-20140243537-A1 | PROCESS FOR THE PREPARATION OF OSELTAMIVIR AND METHYL 3-EPI-SHIKIMATE | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-08-28 | — | — | US | claimed |
| CN-103189969-A | Method and composition for doping silicon substrate with molecular monolayer | DYNALOY LLC | 2013-07-03 | — | — | CN | claimed |
| WO-2013061340-A1 | PROCESS FOR THE PREPARATION OF OSELTAMIVIR AND METHYL 3-EPI-SHIKIMATE | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2013-05-02 | — | — | WO | claimed |
| CN-101921468-B | Polylactic acid composition containing sulfoacid compound and phosphorus-containing organic compound and preparation method thereof | TORAY FIBER RES INST CN CO LTD | 2013-04-24 | — | — | CN | claimed |
| US-20120003826-A1 | METHODS AND COMPOSITIONS FOR DOPING SILICON SUBSTRATES WITH MOLECULAR MONOLAYERS | VERSUM MATERIALS US, LLC | 2012-01-05 | — | — | US | claimed |
| WO-2011112546-A1 | METHODS AND COMPOSITIONS FOR DOPING SILICON SUBSTRATES WITH MOLECULAR MONOLAYERS | DYNALOY, LLC (US) | 2011-09-15 | — | — | WO | claimed |
| CN-101921468-A | Polylactic acid composition containing sulfoacid compound and phosphorus-containing organic compound and preparation method thereof | TORAY FIBER RES INST CN CO LTD | 2010-12-22 | — | — | CN | claimed |
| US-20100101651-A1 | POLYMER SOLAR CELLS | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2010-04-29 | — | — | US | claimed |
| US-20260002280-A1 | COMPOSITION FOR TIN OR TIN ALLOY ELECTROPLATING COMPRISING LEVELING AGENT | BASF SE (DE) | 2026-01-01 | — | — | US | disclosed |
| US-4021461-A | INSECTICIDES | ZOECON CORPORATION (US) | 1977-05-03 | — | — | US | disclosed |
| US-3970704-A | Alkoxy substituted aliphatic di-olefinic halides | ZOECON CORPORATION (US) | 1976-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140243537-A1 | PROCESS FOR THE PREPARATION OF OSELTAMIVIR AND METHYL 3-EPI-SHIKIMATE | CYP51A1, CYP2B6, CYP2C8 | TSHR 4167/4885PPARD 2885/4885TDP1 3761/4885 |
| US-20260002280-A1 | COMPOSITION FOR TIN OR TIN ALLOY ELECTROPLATING COMPRISING LEVELING AGENT | NRAS, TLN1, CLIC1 | TSHR 1731/4885PPARD 4776/4885TDP1 1002/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.